+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Olaparib"

Following a tag allows Research and Markets to customize your experience and provide personalized recommendations.
CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report - Product Thumbnail Image

CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report

  • Report
  • 2189 Pages
Global and Chinese Olaparib (CAS 763113-22-0) Industry - 2017 - Product Thumbnail Image

Global and Chinese Olaparib (CAS 763113-22-0) Industry - 2017

  • Report
  • 150 Pages
From
Olaparib (CAS 763113-22-0) Global and Chinese Market Report - 2016 - Product Thumbnail Image

Olaparib (CAS 763113-22-0) Global and Chinese Market Report - 2016

  • Report
  • 150 Pages
From
Drug Overview: Lynparza - Product Thumbnail Image

Drug Overview: Lynparza

  • Drug Pipelines
  • 61 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 290 Pages
From
Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 273 Pages
From
Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 239 Pages
From
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market - Product Thumbnail Image

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

  • Report
  • 176 Pages
From
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population - Product Thumbnail Image

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population

  • Report
  • 200 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 112 Pages
From
Global Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 110 Pages
From
South America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

South America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 90 Pages
From
North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 90 Pages
From
Middle East & Africa Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Middle East & Africa Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 90 Pages
From
Asia-Pacific Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Asia-Pacific Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 90 Pages
From
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches - Product Thumbnail Image

Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches

  • Report
  • 126 Pages
From
Epithelial Ovarian Cancer: Disease and Pipeline Analysis - Product Thumbnail Image

Epithelial Ovarian Cancer: Disease and Pipeline Analysis

  • Report
  • 98 Pages
From
Loading Indicator
adroll